Ribeiro Elisangela, Matarraz Sudón Sergio, de Santiago María, Lima Carmen S P, Metze Konradin, Giralt Manuel, Saad Sara T O, de Matos Alberto Orfao, Lorand-Metze Irene
Hematology and Hemotherapy Center, State University of Campinas, Brazil.
Leuk Res. 2006 Jan;30(1):9-16. doi: 10.1016/j.leukres.2005.05.019. Epub 2005 Jul 7.
Recent studies concerning the pathophysiology of myelodysplastic syndromes (MDS) have shown evidences for the existence of complex interactions between hematopoietic stem cells and the bone marrow (BM) microenvironment. We analyzed the B-lymphocyte maturation in BM of patients with MDS. For this purpose, 41 newly-diagnosed patients were analyzed. Enumeration and characterization of CD34+ and CD34- B-cell precursors and mature B-lymphocytes was performed using multiparameter flow cytometry. BM from eight transplant donors and six orthopedic surgery patients were used as controls. CD34+/CD45(lo) B-cells were found in 17/22 patients with RA/RARS and in 5/13 with RAEB. In patients with RAEB-t and CMML no CD34+ B-cell precursors could be detected. A positive correlation was found between CD34+ and CD34- B-cell precursors (r=0.52). CD34+ B-cell precursors presented an inverse correlation with BM percentage of blasts and peripheral leukocytes and a positive one with hemoglobin. Asynchronous antigen expression (CD19+/CD79a- cells) was found in 7/11 cases of RA/RARS and 6/18 cases of RAEB in which this phenotype was examined. Abnormal patterns of expression for at least one antigen was found in 91% of RA/RARS cases and in 74% of RAEB. Underexpression of TdT and CD79a were the most frequent abnormalities. Our results present evidences of an abnormal B-cell maturation in MDS. This may be an evidence that B-lymphocytes are derived of the abnormal clone. But it may also be the consequence of influences of abnormalities of BM microenvironment leading to an impaired commitment and maturation of the B-cell line in MDS. Studies performed with purified well-characterized B-cells may further elucidate these abnormalities.
近期关于骨髓增生异常综合征(MDS)病理生理学的研究已证实造血干细胞与骨髓(BM)微环境之间存在复杂的相互作用。我们分析了MDS患者骨髓中的B淋巴细胞成熟情况。为此,对41例新诊断患者进行了分析。使用多参数流式细胞术对CD34 +和CD34 - B细胞前体以及成熟B淋巴细胞进行计数和表征。来自8名移植供体和6名骨科手术患者的骨髓用作对照。在17/22例RA/RARS患者和5/13例RAEB患者中发现了CD34 + / CD45(低)B细胞。在RAEB - t和CMML患者中未检测到CD34 + B细胞前体。CD34 +和CD34 - B细胞前体之间存在正相关(r = 0.52)。CD34 + B细胞前体与骨髓原始细胞百分比和外周血白细胞呈负相关,与血红蛋白呈正相关。在检测该表型的7/11例RA/RARS和6/18例RAEB病例中发现了异步抗原表达(CD19 + / CD79a - 细胞)。在91%的RA/RARS病例和74%的RAEB病例中发现至少一种抗原的异常表达模式。TdT和CD79a的低表达是最常见的异常。我们的结果表明MDS中存在异常的B细胞成熟。这可能表明B淋巴细胞源自异常克隆。但这也可能是骨髓微环境异常影响的结果,导致MDS中B细胞系的定向分化和成熟受损。对纯化的特征明确的B细胞进行的研究可能会进一步阐明这些异常情况。